Application of using streptococcus suis type-2 hy0245 gene encoded proteins as protective antigens
A protective antigen, Streptococcus suis technology, applied in the field of veterinary microbiology and animal infectious diseases, can solve the problems of strong virulence and biological safety hazards, and achieve the effects of good immune protection, production safety, and strong immunogenicity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0018] Embodiment 1 recombinant protein HP0245 EC Cloning and expression of
[0019] In the present invention, the SS2 local isolate SC-19 is used as the source strain of DNA clones encoding extracellular peptides in hp0245. This strain is isolated from a pig with streptococcosis in Sichuan Province in 2005. It is a highly virulent strain with MRP + EF + SLY + Phenotype (see literature Li W, Liu L, Qiu D, ChenH and Zhou R. Identification of Streptococcus suis serotype 2 genes preferential expressed in the natural host. IntJ Med Microb, 2010, 300: 482-488).
[0020] 1. Cloning of DNA encoding extracellular peptides in hp0245
[0021] Using the genome of Streptococcus suis type 2 SC-19 as a template, the applicant designed the hp0245 gene sequence based on the S. suis 05ZYH33 genome sequence published on the NCBI website (http: / / www.ncbi.nlm.nih.gov / ) Upstream primer P1: 5'-GC GAATTC GGTGCTAGTCGAACGTTG-3', where the underlined part is the EcoR I restriction site; downstrea...
Embodiment 2
[0027] Embodiment 2 recombinant protein HP0245 EC Detection of Immunogenicity
[0028] In order to prove that the recombinant protein HP0245 EC It has the characteristics of immunogenicity of the natural protein HP0245 of Streptococcus suis type 2, and can be used as an antigen in the application of a diagnostic test kit for Streptococcus suis type 2 infection, the applicant has passed Western blot method (see Sam Brook and La Searle, Molecular Cloning Experiment Guide, Third Edition, Jin Dongyan et al. (Translation), Science Press, Beijing, 2001) the purified recombinant protein HP0245 EC After SDS-PAGE running, transfer to PVDF membrane, and hybridize it with pig serum infected with Streptococcus suis type 2, the specific steps are as follows: 5 μg recombinant protein HP0245 EC After SDS-PAGE electrophoresis, it was electrotransferred to PVDF membrane (purchased from U.S. Invitrogen Corporation) by transfer membrane instrument (purchased from U.S. Bio-Rad Co.), and PVDF me...
Embodiment 3
[0029] Embodiment 3 recombinant protein HP0245 EC Detection of protection against Streptococcus suis type 2 infection
[0030] 1. For recombinant protein HP0245 EC Evaluation of antibody levels in mice after immunization
[0031] For recombinant protein HP0245 ECTo evaluate the antibody level after immunization, the applicant will use the recombinant protein HP0245 EC , inactivated vaccine and adjuvant control were used to evaluate the antibody level of mice after immunization. The method is: Divide 4-week-old female Balb / c mice into 3 groups, 20 in each group. Group 1 was intraperitoneally injected with 50 μg HP0245 EC . Group 2 was injected with homemade 1 x 10 9 The inactivated vaccine of Streptococcus suis type 2 of CFU, the preparation process of inactivated vaccine is as follows: cultivate Streptococcus suis type 2 overnight with tryptic soybean medium (TSB, purchased from U.S. BD company), then add 0.5% polymer The formaldehyde solution was left to culture for 2...
PUM
Property | Measurement | Unit |
---|---|---|
separation | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com